Vise Technologies Inc. Invests $241,000 in Teladoc Health, Inc. $TDOC

Vise Technologies Inc. purchased a new stake in shares of Teladoc Health, Inc. (NYSE:TDOCFree Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor purchased 27,652 shares of the health services provider’s stock, valued at approximately $241,000.

Other institutional investors have also added to or reduced their stakes in the company. Teacher Retirement System of Texas purchased a new stake in Teladoc Health in the first quarter worth $200,000. Cerity Partners LLC raised its stake in Teladoc Health by 118.8% in the first quarter. Cerity Partners LLC now owns 25,123 shares of the health services provider’s stock worth $200,000 after buying an additional 13,642 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Teladoc Health by 1,037.5% in the 1st quarter. Victory Capital Management Inc. now owns 237,135 shares of the health services provider’s stock worth $1,888,000 after acquiring an additional 216,288 shares in the last quarter. Kestra Private Wealth Services LLC purchased a new stake in shares of Teladoc Health during the first quarter valued at about $259,000. Finally, Allianz Asset Management GmbH lifted its position in Teladoc Health by 105.0% during the first quarter. Allianz Asset Management GmbH now owns 20,700 shares of the health services provider’s stock valued at $165,000 after acquiring an additional 10,600 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on TDOC. Citigroup raised their price target on Teladoc Health from $9.50 to $10.50 and gave the stock a “neutral” rating in a report on Tuesday, October 21st. Zacks Research lowered Teladoc Health from a “strong-buy” rating to a “hold” rating in a report on Monday, November 10th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, October 8th. BMO Capital Markets initiated coverage on Teladoc Health in a research report on Thursday, November 13th. They issued a “market perform” rating and a $8.00 target price on the stock. Finally, Mizuho initiated coverage on shares of Teladoc Health in a research report on Friday, July 25th. They set a “neutral” rating and a $10.00 price target for the company. Five investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Teladoc Health presently has an average rating of “Hold” and a consensus target price of $9.61.

View Our Latest Stock Report on Teladoc Health

Teladoc Health Price Performance

Teladoc Health stock opened at $6.78 on Tuesday. The stock has a market capitalization of $1.20 billion, a P/E ratio of -5.29 and a beta of 1.91. The company’s fifty day moving average price is $8.18 and its 200 day moving average price is $7.76. The company has a debt-to-equity ratio of 0.71, a quick ratio of 2.60 and a current ratio of 2.70. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21.

Teladoc Health (NYSE:TDOCGet Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.05. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The business had revenue of $626.44 million for the quarter, compared to the consensus estimate of $625.66 million. During the same period last year, the firm posted ($0.19) earnings per share. The company’s revenue was down 2.2% compared to the same quarter last year. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. As a group, equities research analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Profile

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Featured Stories

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCFree Report).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.